Search

Your search keyword '"Heikkinen, Tuomas"' showing total 405 results

Search Constraints

Start Over You searched for: Author "Heikkinen, Tuomas" Remove constraint Author: "Heikkinen, Tuomas"
Sorry, I don't understand your search. ×
405 results on '"Heikkinen, Tuomas"'

Search Results

3. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

4. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

5. Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia

6. Large-scale genotyping identifies 41 new loci associated with breast cancer risk

7. Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

8. Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.

9. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.

10. 7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium

11. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.

12. Association Between a Germline OCA2 Polymorphism at Chromosome 15q13.1 and Estrogen Receptor–Negative Breast Cancer Survival

13. Risk of Estrogen Receptor–Positive and –Negative Breast Cancer and Single–Nucleotide Polymorphism 2q35-rs13387042

14. Association of ESR1 gene tagging SNPs with breast cancer risk

16. Supplementary Tables 1-9 from Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

18. Genome-wide association study for ovarian cancer susceptibility using pooled DNA

22. Somatic MED12 Mutations in Prostate Cancer and Uterine Leiomyomas Promote Tumorigenesis Through Distinct Mechanisms

23. Supplement to: Breast-cancer risk in families with mutations in PALB2.

24. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

27. A combined analysis of genome-wide association studies in breast cancer

29. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

30. Breast-Cancer Risk in Families with Mutations in PALB2

31. Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development

32. No evidence that GATA3 rs570613 SNP modifies breast cancer risk

33. Additional file 8 of Exploring the link between MORF4L1 and risk of breast cancer

34. Additional file 7 of Exploring the link between MORF4L1 and risk of breast cancer

35. Additional file 16 of Exploring the link between MORF4L1 and risk of breast cancer

36. Additional file 5 of Exploring the link between MORF4L1 and risk of breast cancer

37. Additional file 9 of Exploring the link between MORF4L1 and risk of breast cancer

38. Additional file of Exploring the link between MORF4L1 and risk of breast cancer

39. Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

41. Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome

42. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium†

43. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

45. Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

46. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

47. Exploring the link between MORF4L1 and risk of breast cancer

49. Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients

50. MOLECULAR CHANGES IN UTERINE LEIOMYOMAS IN MYOMECTOMY PATIENTS

Catalog

Books, media, physical & digital resources